BioPorto A/S
BIOPOR
Rankning i aktier
#22888
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Aktiekurs
$0.15400149
Senast synkroniserad: 2026-10-21
Marknadsvärde
$76.25M
Förändring (1 dag)
-5.83%
Förändring (1 år)
-46.53%
Land
DK
Handel BioPorto A/S (BIOPOR)
Kategori
Healthcare
Aktiekurshistorik för BioPorto A/S (BIOPOR)
Högsta slutkurs: $0.15 den 2026-10-01
Lägsta slutkurs: $0.41 den 2019-12-01
Lägsta slutkurs: $0.41 den 2019-12-01
Aktiekurshistorik för BioPorto A/S från 2019 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | -35.46% |
| 2025 | 0.00% |
| 2024 | -28.16% |
| 2023 | -37.74% |
| 2022 | -14.14% |
| 2021 | 106.94% |
| 2020 | -11.60% |
| 2019 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.05 | 48.68% |
CN
|
|
| $177.93 | 21.98% |
US
|
